£440K
The company has received funding from Innovate UK to apply its artificial intelligence platform to glioblastoma multiforme research.
GlamorousAI develops artificial intelligence platforms for small data drug discovery.
GlamorousAI is an artificial intelligence biotech company that focuses on small data drug discovery. The firm develops technologies to unlock new therapeutic opportunities in oncology and neurodegeneration.
Noor Shaker
CEO

The company has received funding from Innovate UK to apply its artificial intelligence platform to glioblastoma multiforme research.